The Association of the British Pharmaceutical Industry (ABPI) is looking for exciting examples of the innovative use of data from across the life sciences industry, the NHS and academia, that will be showcased to a global community of people interested in the ‘big data’ capabilities within the UK.


The ABPI’s ‘big data demonstrator’ portfolio will provide a unique opportunity for organisations to enhance their visibility and be at the forefront of the development of UK capabilities in the progression of the ‘big data’ agenda.

The ABPI is seeking examples either from innovative projects that have already completed, in progress, or planned for the future. Projects should highlight improvements in either medicine development or healthcare delivery and should involve novel methods of using patient data.

The project portfolio will seek to:

  1. Collect practical experiences in conducting ‘big data’ activities as input for identifying and showcasing the current UK capabilities.

  2. Demonstrate ‘big data’ activities to interested third parties in order to share experiences and best practice in the running of these activities.

The project is part of the four point plan laid out in the ABPI’s ‘big data road map’, which saw four areas of focus, including increasing awareness, building capabilities and capacity, creating sustainable data ecosystems and accelerating high value opportunities.

Commenting on the call for projects ABPI Research, Medical and Innovation Director, Bina Rawal said:

“The ABPI wants to showcase the UK ‘big data’ environment through the development of a demonstrator project portfolio. This portfolio will seek to collect practical experiences in conducting ‘big data’ as input for identifying and showcasing the current UK capabilities, while also demonstrating ‘big data’ activities to interested third parties in order to share experiences and best practices. We are very keen to have a range of examples from across sectors, which will highlight the wide scope of interest in ‘big data’ and the variety of opportunities for future collaborations in the UK.”

Submissions must be made to the ABPI by 12 August 2014. Click here for more information on the projects that the ABPI are interested in.

Notes to editor

About the ABPI

The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.

Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.

The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.

Media enquiries

ABPI Press Office
Telephone: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811
Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.